Superfluid Dx, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Superfluid Dx, Inc. - overview
Established
2015
Location
South San Francisco, CA, US
Primary Industry
Biotechnology
About
Based in California, US, and founded in 2015 by Eric Topol and Stephen Quake, Superfluid Dx, Inc. , f. k. a.
Molecular Stethoscope, Inc. , a. k. a.
Superfluid Dx operates as a health tech company that focuses on developing precise and clinically valuable diagnostic tests through advancements in molecular biology, bioinformatics, and drug development. The company harnesses cell-free mRNA (cf-mRNA) to develop diagnostics. In December 2023, Superfluid Dx, Inc. raised a Series A funding led by WRQ Sciences, with participation from the Alzheimer's Drug Discovery Foundation.
As of May 2024, the company is led by its CEO, Gajus Worthington. The company provides a platform technology using cell-free mRNA (cf-mRNA) for early detection and management of neurodegenerative diseases, including Alzheimer's. The platform’s minimally invasive approach eliminates the need for invasive procedures like spinal taps and inaccurate brain scans. Superfluid's technology facilitates ongoing monitoring and guides therapy decisions by repeating assessments of a patient's disease state over time.
Superfluid Dx plans to use its proceeds from December 2024 funding to develop affordable and accessible biomarkers to diagnose Alzheimer's disease and related dementias and advance the clinical development of more targeted treatments.
Current Investors
Index Ventures, Pfizer Inc., DCVC
Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Diagnostic, Medical & Imaging Laboratories
Website
www.superfluiddx.com
Verticals
HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.